23andMe is using its customers’ genetic data to try to become a new kind of pharma company. By Kristen V. Brown

The CEO Playbook to Navigating Trump
18:56

The Dawn of Music’s AI Era
32:43

The Startup Making Human Embryos With AI-Assisted Robots
37:40